What is the recommended dose of Ryaltris (olopatadine hydrochloride and mometasone furoate) for an 8-year-old patient with allergic rhinitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ryaltris (olopatadine hydrochloride and mometasone furoate) is not recommended for an 8-year-old patient with allergic rhinitis due to the lack of established safety and efficacy in this age group. The provided evidence does not specifically mention the recommended dose of Ryaltris for an 8-year-old patient, but it does provide information on other intranasal steroids and their approved age ranges [ 1 ]. Given the information available, it is clear that most intranasal steroids have specific age restrictions, and Ryaltris, being a combination of an antihistamine and a corticosteroid, would likely have similar or more stringent restrictions. Some key points to consider when treating an 8-year-old patient with allergic rhinitis include:

  • The use of single-ingredient nasal sprays, such as fluticasone or mometasone, which have established safety profiles in pediatric populations [ 1 ].
  • The consideration of oral antihistamines approved for use in children under 12 years old.
  • The importance of consulting the FDA-approved labeling for any medication to ensure it is appropriate for the patient's age group. It is essential to prioritize the patient's safety and consider alternative treatments that have been established as safe and effective for an 8-year-old patient with allergic rhinitis [ 1 ].

From the FDA Drug Label

Children age 2 to 11 An adult should supervise use Use one spray in each nostril once daily.

The recommended dose of Ryaltris (olopatadine hydrochloride and mometasone furoate) for an 8-year-old patient with allergic rhinitis is one spray in each nostril once daily.

From the Research

Ryaltris Dose for 8-Year-Old Patient

  • The recommended dose of Ryaltris (olopatadine hydrochloride and mometasone furoate) for an 8-year-old patient with allergic rhinitis is not directly stated in the provided studies 2, 3, 4, 5, 6.
  • However, the studies discuss the efficacy and safety of various nasal sprays, including azelastine and fluticasone, which are components of Ryaltris.
  • According to the studies, azelastine and fluticasone have comparable efficacy in symptom control in patients with allergic rhinitis 4.
  • The studies also suggest that a combination of azelastine and fluticasone, such as Ryaltris, may provide greater symptom relief than either component alone 3, 5, 6.
  • However, the specific dose of Ryaltris for an 8-year-old patient is not mentioned in the provided studies.
  • It is essential to consult the prescribing information or a healthcare professional to determine the recommended dose of Ryaltris for a specific patient, as the dose may vary depending on the individual's needs and medical history.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Azelastine and fluticasone nasal spray: any advantage?

Drug and therapeutics bulletin, 2014

Research

Comparison of the Effects of Azelastine and Fluticasone Nasal Sprays in the Treatment of Allergic Rhinitis.

Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2022

Research

Intranasal spray medications for maintenance therapy of allergic rhinitis.

American journal of rhinology & allergy, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.